Prognostic Significance of Chromosomal Aberrations in Philadelphia Chromosome Negative Metaphases during Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia

被引：0
|
作者：
Batra, R. [1 ]
Weisenburger, D. [1 ]
Snyder, D. [1 ]
Bedell, V. [1 ]
Murata-Collins, J. [1 ]
Gaal, K. [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1380
引用
收藏
页码：335A / 335A
页数：1
相关论文
共 50 条
  • [1] Prognostic Significance of Chromosomal Aberrations in Philadelphia Chromosome Negative Metaphases during Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia
    Batra, R.
    Weisenburger, D.
    Snyder, D.
    Bedell, V.
    Murata-Collins, J.
    Gaal, K.
    MODERN PATHOLOGY, 2014, 27 : 335A - 335A
  • [2] Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase
    Medina, J
    Kantarjian, H
    Talpaz, M
    O'Brien, S
    Garcia-Manero, G
    Giles, F
    Rios, MB
    Hayes, K
    Cortes, J
    CANCER, 2003, 98 (09) : 1905 - 1911
  • [3] Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase
    Jootar, S.
    BLOOD REVIEWS, 2007, 21 : S121 - S121
  • [4] Prognostic significance of standard Philadelphia chromosome versus Philadelphia chromosome with additional chromosomal abnormalities on survival of patients with chronic myelogenous leukemia.
    Hematti, P
    Hoeltge, GA
    Rybicki, LA
    Lichtin, AE
    BLOOD, 1997, 90 (10) : 3696 - 3696
  • [5] Isolated Clonal Trisomy 13 in Philadelphia Chromosome-Negative Metaphases in Patients with Chronic Myelogenous Leukemia
    Yin, C. C.
    Hu, S.
    Medeiros, L. J.
    Lu, G.
    MODERN PATHOLOGY, 2012, 25 : 383A - 383A
  • [6] Isolated Clonal Trisomy 13 in Philadelphia Chromosome-Negative Metaphases in Patients with Chronic Myelogenous Leukemia
    Yin, C. C.
    Hu, S.
    Medeiros, L. J.
    Lu, G.
    LABORATORY INVESTIGATION, 2012, 92 : 383A - 383A
  • [7] Long-term follow-up of chronic myelogenous leukemia patients with novel chromosomal aberrations in Philadelphia chromosome-negative cells treated with tyrosine kinase inhibitors
    Papaioannou, George
    Gaitatzi, Maria
    Touloumenidou, Tasoula
    Anagnostopoulos, Achilles
    Athanasiadou, Anasatasia
    CHROMOSOME RESEARCH, 2011, 19 : S148 - S148
  • [8] NOVEL CHROMOSOMAL ABERRATIONS IN PHILADELPHIA-CHROMOSOME NEGATIVE CELLS OF A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH BCR/ABL KINASE INHIBITORS
    Athanasiadou, A.
    Papaioannou, G.
    Gaitatzi, M.
    Karpouza, A.
    Touloumenidou, T.
    Lazarou, Z.
    Batsis, I.
    Vadikolia, C.
    Lalayanni, C.
    Stavroyianni, N.
    Saloum, R.
    Fassas, A.
    Anagnostopoulos, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 431 - 431
  • [9] Chromosomal abnormalities in Philadelphia chromosome (Ph)-negative metaphases appearing during novel tyrosine kinase inhibitors (NTKI) therapy in patients (pts) with chronic myeloid leukemia (CML) after imatinib-failure.
    Jabbour, Elias
    Kantarjian, Hagop
    Abruzzo, Lynne
    Giles, Francis
    Rios, Mary Beth
    Cortes, Jorge
    BLOOD, 2006, 108 (11) : 600A - 600A
  • [10] Chromosomal Abnormalities In Philadelphia Chromosome (Ph)-Negative Metaphases Appearing During Second Generation Tyrosine Kinase Inhibitors (2nd TKI) Therapy In Patients (pts) with Chronic Myeloid Leukemia (CML)
    Jabbour, Elias
    Kantarjian, Hagop
    Cornelison, A. Megan
    Kadia, Tapan
    Welch, Mary-Alma
    Abruzzo, Lynne V.
    Burger, Jan A.
    Ferrajoli, Alessandra
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    BLOOD, 2010, 116 (21) : 527 - 527
12345